Cargando…
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab
Background: In clinical trials with immunotherapy, histological features such as tumor-infiltrating lymphocytes (TILs) are investigated as potential predictive biomarkers, with the limit of an outdated parameter for a typically dynamic element. Methods: This explorative study compared, in metastatic...
Autores principales: | Bersanelli, Melissa, Gnetti, Letizia, Vaglio, Augusto, Sverzellati, Nicola, Campanini, Nicoletta, Incerti, Monia, Galetti, Maricla, Varotti, Elena, Corrado, Michele, Parziale, Raffaele, Bottarelli, Lorena, Azzoni, Cinzia, Silini, Enrico Maria, Leonardi, Francesco, Buti, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233785/ https://www.ncbi.nlm.nih.gov/pubmed/31910171 http://dx.doi.org/10.23750/abm.v90i4.7057 |
Ejemplares similares
-
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity
por: Bersanelli, Melissa, et al.
Publicado: (2023) -
Pazopanib as a possible option for the treatment of metastatic
non-clear cell renal carcinoma patients: a systematic review
por: Bersanelli, Melissa, et al.
Publicado: (2020) -
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?
por: Negri, Francesca, et al.
Publicado: (2023) -
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series
por: Negri, Francesca, et al.
Publicado: (2019) -
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case report
por: Minari, Roberta, et al.
Publicado: (2020)